Decrease the Frequency of Inappropriate Intravenous Lines in Internal Medicine (PERMI)

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Stephane Mouly, MD PhD, Hopital Lariboisière

ClinicalTrials.gov Identifier:

NCT01633307

First received: June 19, 2012

Last updated: July 3, 2012

Last verified: June 2012

History of Changes

Purpose

Aim: to determine whether a nationwide teaching program delivered to medical doctors can decrease the use of inappropriate intravenous lines in internal medicine

Condition	Intervention	Phase
Acute Medical Patients Hospitalized in Internal Medicine	Other: Education	Phase 4

Study Type:	Interventional
Study Design:	Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label
Official Title:	Effect of a Nationwide Teaching Program on the Frequency of Inappropriate Intravenous Lines in Internal Medicine: A Randomized Controlled Trial

Further study details as provided by Hopital Lariboisière:

Primary Outcome Measures:

frequency of inappropriate intravenous infusion in internal medicine department [ Designated as safety issue: No ]

Enrollment:	59
Study Start Date:	January 2007
Study Completion Date:	May 2007
Primary Completion Date:	April 2007 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
Experimental: Experimental Intervention (Teaching program)	Other: Education Teaching program
No Intervention: Control group No teaching program

Detailed Description:

Nationwide multicentre randomized prospective controlled trial enrolling 59 french internal medicine departments. During the first study visit, we collected data of patients with intravenous infusions from each participating centre in order to determine the number and frequency of inappropriate intravenous lines. Using a computerized randomization process (on a 1:1 basis), the participating centres were randomized; Half centres (interventional group) received an educational program consisting of educational material and two educational sessions; the other half did not receive the educational program (control group). The educational program provided medical doctors with posters and slides containing information on valid indications for the prescription and use of intravenous infusions (inability to drink or eat, malabsorption, medication only available intravenously with no oral equivalent). Based on a previous pilot study, we assumed that the the frequency of inappropriate intravenous lines with be approximately 20% at baseline and hypothesize that the nationwide teaching program will decrease this frequency by 50%.

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Internal medicine department

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT01633307

Sponsors and Collaborators

Hopital Lariboisière

Investigators

Principal Investigator:

stephane J mouly, MD PhD

Hopital Lariboisiere

More Information

No publications provided

Responsible Party:	Stephane Mouly, MD PhD, Professor of Medicine, Hopital Lariboisière
ClinicalTrials.gov Identifier:	NCT01633307 History of Changes
Other Study ID Numbers:	PERMI
Study First Received:	June 19, 2012
Last Updated:	July 3, 2012
Health Authority:	France: Ministry of Health

Keywords provided by Hopital Lariboisière:

education
intravenous infusion

ClinicalTrials.gov processed this record on May 16, 2013

To Top